MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Does motor laterality affect the development of dyskinesia in patients with Parkinson’s disease?

S. Chung, H. Yoo, J. Oh, J. Kim, P. Lee, Y. Sohn (Seoul, Republic of Korea)

Meeting: 2018 International Congress

Abstract Number: 366

Keywords: Dyskinesias, Levodopa(L-dopa)

Session Information

Date: Saturday, October 6, 2018

Session Title: Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: To investigate the effects of motor laterality on the development of levodopa-induced dyskinesia (LID) in patients with de novo Parkinson’s disease (PD).

Background: LID occurs in most patients with PD within several years as a consequence of chronic dopamine replacement therapy. In general, younger age of onset and severity of PD, and higher doses and longer duration of levodopa treatment are closely associated with the early development of LID. Motor laterality, however, has not been assessed as a risk factor for LID.

Methods: We reviewed the medical records of 560 patients with PD who were treated with PD medications at least for 2.5 years from the Yonsei Parkinson Center database. Among them, 390 with documented right-handedness had asymmetric and lateralized motor symptoms (193 with right-side dominant PD and 197 with left-side dominant PD). We assessed the effects of motor laterality on the development of LID with Kaplan-Meier estimates and time-dependent Cox regression model based on the time point of 5 years, adjusting for the age of PD onset, dopamine transporter (DAT) availability of the posterior putamen, and levodopa-equivalent dose.

Results: The right-side-dominant PD group had milder parkinsonian motor symptoms compared with the left-side-dominant group, despite their comparable DAT availability in the posterior putamen. LID developed in 46 (23.4%) with right-side dominant PD (follow-up duration, 4.81 years) and in 35 (18.1%) patients with left-side dominant PD (follow-up duration, 4.73 years). The Kaplan-Meier analyses revealed that the left-side-dominant group developed LID earlier than the right-side-dominant group (PBreslow = 0.027). The time-dependent Cox regression model showed that the hazard ratio for the development of LID within 5 years of the left-side-dominant group was 1.978 (95% confidence interval, 1.066-3.669, p = 0.031) compared with the right-side dominant group, whereas the risk for developing LID after 5 years was similar between the two groups (p = 0.360).

Conclusions: These findings suggest that the plasticity of the striato-cortical motor networks may differ between the dominant and non-dominant hemispheres, which affects the risk for the early development of LID according to the motor laterality in patients with PD.

To cite this abstract in AMA style:

S. Chung, H. Yoo, J. Oh, J. Kim, P. Lee, Y. Sohn. Does motor laterality affect the development of dyskinesia in patients with Parkinson’s disease? [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/does-motor-laterality-affect-the-development-of-dyskinesia-in-patients-with-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/does-motor-laterality-affect-the-development-of-dyskinesia-in-patients-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley